[Causes and outcomes of coronary arteries perforations]

Kardiologiia
|May 20, 2006
PubMed

Insights

Coronary artery perforation during percutaneous coronary intervention is rare but serious. Outcomes improved over time, with declining rates of adverse events and mortality, suggesting enhanced procedural safety.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Medicine

Context:

  • Percutaneous coronary interventions (PCI) are common procedures for treating coronary artery disease.
  • Coronary artery perforation (CAP) is a rare but significant complication of PCI.
  • Understanding CAP predictors and outcomes is crucial for improving patient safety.

Purpose:

  • To evaluate in-hospital and long-term outcomes of patients experiencing coronary artery perforation during PCI.
  • To identify predictors associated with the occurrence of coronary artery perforation.
  • To analyze trends in CAP rates and associated adverse events over time.

Summary:

  • A study of 127 patients (1.08% of PCI cases) who experienced coronary artery perforation between 1997 and 2002.
  • Identified predictors included complex stenoses, chronic occlusions, calcified lesions, small vessel lumen, and specific devices (excimer laser, thromboextractor).
  • Observed a decline in perforation rates, cardiac tamponade, urgent coronary artery bypass surgery, and mortality throughout the study period.

Impact:

  • Demonstrates a trend towards improved safety in PCI procedures, with reduced complication rates.
  • Highlights key factors contributing to coronary artery perforation, aiding in risk stratification and prevention strategies.
  • Provides valuable data for interventional cardiologists to refine techniques and patient selection for PCI.

Related Concept Videos

Esophageal Perforation-I: Introduction01:22

Esophageal Perforation-I: Introduction

Esophageal perforation is a severe medical condition characterized by a breach in the integrity of the esophageal wall. This breach can occur due to various factors such as trauma, medical procedures, or underlying diseases. When the esophageal wall is compromised, it allows food, fluids, and digestive juices into the chest cavity or adjacent structures, leading to potential complications and health risks.
The location of esophageal perforation can vary, occurring anywhere along the esophagus.
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...